Stockholm, Sweden

Christer Svedman

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Genomic Health, Inc., N-Power Medicine, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christer Svedman. Retrieved from https://idiyas.com/inventor/christer-svedman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Christer Svedman

Introduction

Christer Svedman is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of molecular assays, particularly in the context of kidney cancer. With a total of 3 patents, Svedman's work focuses on improving patient outcomes through innovative algorithms.

Latest Patents

Svedman's latest patents include a gene expression profile algorithm designed for calculating a recurrence score for patients with kidney cancer. This invention provides algorithm-based molecular assays that involve measuring the expression levels of genes from biological samples obtained from kidney cancer patients. The methods developed allow for obtaining a quantitative score based on these measurements. The genes can be grouped into functional gene subsets for calculating the score, and these subsets may be weighted according to their contribution to cancer recurrence.

Career Highlights

Svedman is currently associated with Genomic Health, Inc., where he continues to advance his research and innovations. His work is pivotal in the development of personalized medicine approaches for cancer treatment.

Collaborations

Some of his notable coworkers include Steven Shak and George Andrew Watson, who have also contributed to advancements in genomic health.

Conclusion

Christer Svedman's contributions to the field of molecular assays and cancer research highlight the importance of innovation in improving patient care. His work exemplifies the potential of technology to transform medical practices and enhance treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…